Search

everythinglearnresearchcommunity

for

Search:↓

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.

The Rotterdam Study aims to understand various diseases in older adults.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

Tight junctions are key for skin protection and controlling what gets absorbed or passes through the skin.

Accurate diagnosis and effective oral treatment are key to managing tinea capitis and preventing its spread.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

Foxp3 is crucial for regulatory T cell function, and targeting these cells may help treat immune disorders.

Adult female acne treatment should be personalized, considering individual preferences and pregnancy, using various topical and oral medications while managing side effects and resistance.

Restoring hair bulb immune privilege is crucial for managing alopecia areata.

Hyaluronidase speeds up wound healing and reduces inflammation.

Turing patterns are now recognized as important in developmental biology.

Future acne treatments should aggressively target inflammation to prevent scarring.

Stress hormone corticosterone blocks a growth factor to slow down hair stem cell activity and hair growth.

Atopic dermatitis is common in developing countries, but many patients receive poor care due to inconsistent guidelines and lack of resources.

Dermal Papilla cells are a promising tool for evaluating hair growth treatments.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction and reduced sexual desire, sometimes lasting after stopping the drug.

Human hair follicles produce and respond to erythropoietin, helping protect against stress.

Nanoparticles don't penetrate intact skin but can enter through pores or damaged skin.

Men taking 5α-reductase inhibitors for enlarged prostate have a higher chance of experiencing reduced sexual desire and erectile dysfunction.

Mood stabilizers like lithium and anticonvulsants have side effects that can lead to patients stopping their medication, and managing these effects is important for treatment adherence.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Researchers found 15 new genetic links to skin traits in Japanese women.

Liposomes improve finasteride delivery for hair loss treatment, making it a promising option for topical use.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

Dupilumab for eczema may cause hair loss.

New genes found linked to balding, may help develop future treatments.